SP 7.08 Predictive Value of Body Composition Parameters for Pathological Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric

Clicks: 2
ID: 323977
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #135 of 432 articles by views in the british journal of surgery

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 432 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Background The predictive value of body composition for pathological response to neoadjuvant immunochemotherapy (NICT) in locally advanced gastric cancer (LAGC) is unclear. This study aimed to investigate its impact. Methods This retrospective study included 261 LAGC patients admitted to the First Hospital of Lanzhou University from January 1, 2021, to December 31, 2024, who received NICT and subsequently underwent radical gastrectomy. Based on postoperative pathological evaluation, patients were divided into the Major Pathological Response group (MPR, n=84) and the Incomplete Pathological Response group (IPR, n=177). Utilizing pre- and post-NICT abdominal CT images, various body composition parameters were measured at the level of the third lumbar vertebra (L3). Various statistical methods were employed to systematically screen for independent predictive factors of pathological response after NICT. Results Skeletal muscle density (SMD) decreased most significantly (38.9±6.6 vs. 29.7±3.8 HU, P<0.001). Multivariate logistic regression analysis revealed that the absolute decrease in SMI during treatment was an independent negative predictor for MPR (OR: 1.116, 95% CI: 1.015-1.225, P=0.023). Diagnostic analysis confirmed that both pre-treatment sarcopenia (22.6% vs 39.0%, P=0.009) and post-treatment sarcopenia (20.2% vs 44.1%, P<0.001) were significantly associated with poorer pathological response. Nutritional and body composition parameters decreased post-NICT. Conclusion Progressive muscle loss during NICT independently predicts pathological response in LAGC. Dynamic monitoring of body composition could help identify patients with poor prognosis early, informing potential interventions. Keywords Gastric cancer, Neoadjuvant immunochemotherapy, Skeletal muscle index, Sarcopenia, Pathological response, Body composition
Reference Key
openalex_W7172487708 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Xinglong Lu, Jianling Zhang, Xiang Cui, Yongjiang Yu, Wenzhen Yuan, Fanghui Ding
Journal the british journal of surgery
Year 2026
DOI
10.1093/bjs/znag087.095
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.